| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CFO | President and CFO
1 company
Andrew Guggenhime is President and CFO at PCVX. From November 2021 to September 2026, the filings on record show 0 open-market purchases and 32 sales. Andrew Guggenhime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.8M at current prices.
Our model assigns Andrew Guggenhime a below-average insider score of 46/100, based on 33 past trades. Over a 12-month horizon, 35.5% of those trades were profitable, with an average 12-month return of -27.5%.
The PCVX filings lean toward selling, a net 284,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $81.17 | $649,325.13 | -7.6% | +48.2% | -54.5% | |
| Jun 18, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $71.92 | $575,374.72 | -7.6% | +58.1% | -53.8% | |
| May 20, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $74.99 | $599,909.18 | -7.7% | +4.1% | -51.8% | |
| Apr 18, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $61.27 | $490,199.41 | -7.7% | +34.2% | -49.4% | |
| Mar 18, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $69.02 | $552,143.75 | -7.7% | +5.6% | +9.8% | |
| Feb 20, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $74.53 | $596,231.64 | -9.1% | +2.5% | +12.5% | |
| Jan 18, 2024 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $60.73 | $485,878.63 | -9.1% | +2.6% | +40.2% | |
| Dec 18, 2023 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $60.18 | $481,416.77 | -9.1% | +12.7% | +48.9% | |
| Dec 14, 2023 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 14,000 | $60.22 | $843,080.00 | -15.0% | +20.9% | +44.8% | |
| Nov 20, 2023 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $51.13 | $409,062.92 | -9.1% | +44.1% | +69.4% |